Lannett initiates human testing of biosimilar insulin product
June 05, 2019 at 14:14 PM EDT
The Northeast Philadelphia generic drug company is co-developing the biosimilar with a Canadian partner.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|